Latest News about FDA Breakthrough Designation
Recent news which mentions FDA Breakthrough Designation
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Secures FDA Breakthrough Therapy Tag For Its Influenza Immunotherapy
April 18, 2023
Tickers
SABS
From Benzinga
IVERIC bio Secures Breakthrough Therapy Tag For Its Flagship Geographic Atrophy Candidate
November 18, 2022
Tickers
ISEE
From Benzinga
FDA Denies Breakthrough Tag For NRx Pharma's COVID-19 Candidate
November 24, 2021
From Benzinga
Roche's Alzheimer's Candidate Secures FDA Breakthrough Designation
October 08, 2021
From Benzinga
CytoSorbents' Antithrombotic Removal System Scores Second FDA Breakthrough Device Tag
August 12, 2021
From Benzinga
Junshi Biosciences, Coherus Receive FDA Breakthrough Therapy Status For Toripalimab In Head & Neck Cancer
August 12, 2021
Tickers
CHRS
From Benzinga
Hancock Jaffe Stock Surges On FDA Breakthrough Designation For Its Venous Insufficiency Device
August 03, 2021
Tickers
HJLI
From Benzinga
AbbVie - Roche's Venclexta Receives Breakthrough Therapy Tag In High-Risk Myelodysplastic Syndromes
July 21, 2021
From Benzinga
NeuroMetrix Stock Surges As Its Nerve Stimulator Scores FDA Breakthrough Designation For Fibromyalgia
July 20, 2021
Tickers
NURO
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
